392630-73-8 Usage
Uses
Used in Pharmaceutical Industry:
4-(2,2-DIMETHOXY-ETHYL)-PHENYLAMINE is used as a building block for the synthesis of various pharmaceuticals and organic compounds. Its unique structure and properties make it a valuable component in the development of new drugs with potential therapeutic applications.
Used in Research and Development:
4-(2,2-DIMETHOXY-ETHYL)-PHENYLAMINE is used as a research compound for studying its biological activity and potential applications in drug development. Its promising results in certain research studies indicate that it may have a role in the creation of innovative therapeutic agents.
Used in Organic Chemistry:
4-(2,2-DIMETHOXY-ETHYL)-PHENYLAMINE is used as a reagent or intermediate in various organic chemical reactions. Its presence in the synthesis of complex organic molecules highlights its versatility and importance in the field of organic chemistry.
Check Digit Verification of cas no
The CAS Registry Mumber 392630-73-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,9,2,6,3 and 0 respectively; the second part has 2 digits, 7 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 392630-73:
(8*3)+(7*9)+(6*2)+(5*6)+(4*3)+(3*0)+(2*7)+(1*3)=158
158 % 10 = 8
So 392630-73-8 is a valid CAS Registry Number.
392630-73-8Relevant articles and documents
HETEROCYCLIC BETA-3 ADRENERGIC RECEPTOR AGONISTS
-
, (2008/06/13)
This invention provides compounds of Formula I having the structure U, V, W, X, and Y are as defined hereinbefore, or a pharmaceutically acceptable salt thereof, which are useful in treating or inhibiting metabolic disorders related to insulin resistance or hyperglycemia (typically associated with obesity or glucose intolerance), atherosclerosis, gastrointestinal disorders, neurogenetic inflammation, glaucoma, ocular hypertension and frequent urination; and are particularly useful in the treatment or inhibition of type II diabetes.
4-Aminopiperidine ureas as potent selective agonists of the human β3-Adrenergic receptor
Ashwell, Mark A,Solvibile Jr., William R,Han, Stella,Largis, Elwood,Mulvey, Ruth,Tillet, Jeffrey
, p. 3123 - 3127 (2007/10/03)
The preparation and structure-activity relationships (SARs) of potent agonists of the human β3-adrenergic receptor (AR) derived from a 4-aminopiperidine scaffold are described. Examples combine human β3-AR potency with selectivity over human β1-AR and/or human β2-AR agonism. Compound 29s was identified as a potent (EC50 = 1 nM) and selective (greater than 400-fold over β1- with no β2-AR agonism) full β3-AR agonist with in vivo activity in a transgenic mouse model of thermogenesis.
